Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NewNeural LLC
Profile last edited on: 12/21/06      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2004
Latest Award
2005
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

8S070 Greene Road
Naperville, IL 60540
   (630) 297-7492
   info@newneural.com
   www.newneural.com
Location: Single
Congr. District: 11
County: DuPage

Public Profile

NewNeural intends to develop autologous (from the patient) cell therapies using easily obtained cells (marrow) to treat central nervous system (CNS) diseases and injuries. NewNeural’s initial focus will be to generate decisive efficacy data in an upper level animal model of stroke. Additional safety and manufacturing information will be combined with this efficacy data to support an investigational New Drug (IND) application for New Neural’s cell therapy for str

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$237,901
Phase II Dollars
$0
Total Awarded
$237,901

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2005 1 NIH $101,115
Project Title: Characterizing marrow derived cells for neural therapy
2004 1 NIH $136,786
Project Title: Enhanced Neural Stem Cell Production in the Aging Brain

Key People / Management

  Robert Gonzalez -- President

  Kendrick C Boardman

Company News

There are no news available.